-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D3gqwKVErMqNED65NWkHafJCpL+0Mp1DE2ZmkDSKL45uGUf/g8z/tbo3KAR0bAk7 8F58uO7dNc+dQDTrAXX1oQ== 0000030167-09-000014.txt : 20091029 0000030167-09-000014.hdr.sgml : 20091029 20091029095302 ACCESSION NUMBER: 0000030167-09-000014 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090831 FILED AS OF DATE: 20091029 DATE AS OF CHANGE: 20091029 EFFECTIVENESS DATE: 20091029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DREYFUS THIRD CENTURY FUND INC CENTRAL INDEX KEY: 0000030167 IRS NUMBER: 132691318 STATE OF INCORPORATION: MD FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-02192 FILM NUMBER: 091143408 BUSINESS ADDRESS: STREET 1: THE DREYFUS CORPORATION STREET 2: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2129226883 MAIL ADDRESS: STREET 1: C/O DREYFUS CORP STREET 2: 200 PARK AVENUE, 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS PREMIER THIRD CENTURY FUND INC DATE OF NAME CHANGE: 20020517 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS THIRD CENTURY FUND INC DATE OF NAME CHANGE: 19920703 0000030167 S000000095 DREYFUS THIRD CENTURY FUND INC C000000149 Class A DTCAX C000000150 Class B DTCBX C000000151 Class C DTCCX C000000152 Class I DRTCX C000000154 Class Z DRTHX N-Q 1 formnq035.htm FORM N-Q formnq035.htm - Generated by SEC Publisher for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT
INVESTMENT COMPANY

Investment Company Act file number  811-2192 

The Dreyfus Third Century Fund, Inc.
(Exact name of Registrant as specified in charter)

c/o The Dreyfus Corporation
200 Park Avenue
New York, New York 10166
(Address of principal executive offices) (Zip code)

Michael A. Rosenberg, Esq.
200 Park Avenue
New York, New York 10166
(Name and address of agent for service)

Registrant's telephone number, including area code:  (212) 922-6000 

Date of fiscal year end:  5/31 
Date of reporting period:  8/31/2009 



FORM N-Q

Item 1.  Schedule of Investments. 

 



STATEMENT OF INVESTMENTS     
The Dreyfus Third Century Fund, Inc.     
August 31, 2009 (Unaudited)     
 
 
Common Stocks--98.8%  Shares  Value ($) 
Consumer Discretionary--8.2%     
Coach    94,325  2,668,454 
DeVry    26,550  1,356,705 
DreamWorks Animation SKG, Cl. A    57,750 a  1,949,640 
Gap  180,050  3,537,982 
McDonald's    41,975  2,360,674 
Priceline.com    19,025 a,b  2,929,470 
TJX Cos.    81,725  2,938,014 
Weight Watchers International    30,100 b  825,643 
    18,566,582 
Consumer Staples--12.9%     
Bare Escentuals    46,575 a  432,216 
Church & Dwight    45,300  2,587,989 
Costco Wholesale    77,175  3,934,381 
Hansen Natural    49,975 a,b  1,632,184 
Kimberly-Clark    64,075  3,873,975 
PepsiCo  133,550  7,568,279 
Procter & Gamble  107,000  5,789,770 
SYSCO    68,025  1,733,957 
Unilever (NY Shares)    65,850 b  1,839,191 
    29,391,942 
Energy--8.1%     
EnCana    23,975  1,246,460 
ENSCO International    51,025  1,882,822 
EOG Resources    22,750  1,638,000 
Nexen  100,275  1,971,407 
Noble  106,850  3,742,955 
SEACOR Holdings    28,525 a,b  2,171,608 
Southwestern Energy    72,925 a  2,688,016 
Talisman Energy  188,625  3,029,318 
    18,370,586 
Financial--6.9%     
Charles Schwab  125,400  2,264,724 
Chubb    43,750  2,160,812 
Discover Financial Services  227,125  3,122,969 
Eaton Vance    78,425 b  2,240,602 
Goldman Sachs Group      7,225  1,195,448 



State Street   43,000  2,256,640 
Travelers Cos.   46,225  2,330,665 
    15,571,860 
Health Care--15.8%     
Aetna   76,000  2,166,000 
Alcon   15,875  2,055,336 
Amgen   82,025 a  4,900,173 
AstraZeneca, ADR   46,025 b  2,146,146 
Becton, Dickinson & Co.   61,500  4,281,630 
Biogen Idec   41,100 a  2,063,631 
Genzyme   69,950 a  3,896,915 
Gilead Sciences   49,800 a  2,243,988 
Johnson & Johnson   84,300  5,095,092 
Novartis, ADR   24,675  1,146,647 
WellPoint   83,200 a  4,397,120 
Zimmer Holdings   31,450 a  1,489,158 
    35,881,836 
Industrial--12.5%     
3M   51,025  3,678,903 
Danaher   28,425  1,725,682 
Donaldson   24,725 b  928,918 
Dun & Bradstreet   19,925  1,455,322 
Emerson Electric  131,075  4,832,735 
Equifax   41,575 b  1,149,133 
First Solar     8,300 a,b  1,009,114 
Fluor   26,650  1,409,785 
Rockwell Collins   71,100  3,273,444 
Ryder System   22,650 b  860,700 
Tyco International   59,025  1,870,502 
United Technologies  106,400  6,315,904 
    28,510,142 
Information Technology--24.3%     
Apple   50,075 a  8,423,116 
Accenture, Cl. A   92,550  3,054,150 
Avnet   48,700 a  1,297,855 
Cisco Systems  267,075 a  5,768,820 
EMC  183,975 a  2,925,202 
Google, Cl. A     9,850 a  4,547,449 
Intel   66,050  1,342,136 
International Business Machines   87,300  10,305,765 
National Semiconductor  115,900 b  1,758,203 
QUALCOMM  111,150  5,159,583 
STMicroelectronics (New York     



       Shares)   90,025 b  779,617 
Sybase   48,400 a  1,686,740 
Symantec   84,200 a  1,273,104 
Texas Instruments  206,800  5,085,212 
Western Union   98,675  1,780,097 
    55,187,049 
Materials--1.4%     
Nucor   38,950  1,734,833 
Schnitzer Steel Industries, Cl. A   25,900  1,398,859 
    3,133,692 
Software--5.5%     
Microsoft  428,000  10,550,200 
Oracle   94,275  2,061,794 
    12,611,994 
Telecommunication Services--.6%     
Windstream  168,900  1,447,473 
Utilities--2.6%     
FPL Group   27,825  1,563,208 
Sempra Energy   68,625  3,442,916 
WGL Holdings   28,775 b  949,575 
    5,955,699 
Total Common Stocks     
       (cost $230,241,949)    224,628,855 
 
Other Investment--1.1%     
Registered Investment Company;     
Dreyfus Institutional Preferred     
       Plus Money Market Fund     
       (cost $2,559,000)  2,559,000 c  2,559,000 
Investment of Cash Collateral for     
Securities Loaned--5.8%     
Registered Investment Company;     
Dreyfus Institutional Cash     
       Advantage Plus Fund     
       (cost $13,212,204)  13,212,204 c  13,212,204 
Total Investments (cost $246,013,153)  105.7%  240,400,059 
Liabilities, Less Cash and Receivables  (5.7%)  (13,080,771) 
Net Assets  100.0%  227,319,288 
 
ADR - American Depository Receipts     

a      Non-income producing security.
b      All or a portion of these securities are on loan. At August 31, 2009, the total market value of the fund's securities on loan is $12,799,178 and the total market value of the collateral held by the fund is $13,212,204.


c Investment in affiliated money market mutual fund.

At August 31, 2009, the aggregate cost of investment securities for income tax purposes was $246,013,153. Net unrealized depreciation securities on investments was $5,613,094 of which $14,616,777 related to appreciated investment securities and $20,229,871 related to depreciated investment



Various inputs are used in determining the value of the fund's investments relating to FAS 157. These inputs are summarized in the three broad levels listed below. 
 
                 Level 1 - quoted prices in active markets for identical investments. 
                 Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, 
                               credit risk, etc.). 
                 Level 3 - significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments). 
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing 
in those securities. 
The following is a summary of the inputs used as of August 31, 2009 in valuing the fund's investments: 

    Level 2 - Other Significant  Level 3 -Significant Unobservable   
Assets ($)  Level 1 -Quoted Prices  Observable Inputs  Inputs  Total 
Investments in Securities:         
Equity Securities - Domestic  210,414,733  -  -  210,414,733 
Equity Securities - Foreign  14,214,122  -  -  14,214,122 
Mutual Funds  15,771,204  -  -  15,771,204 
Other Financial Instruments+  -  -  -  - 
Liabilities ($)         
Other Financial Instruments+  -  -  -  - 
† Other financial instruments include derivative instruments, such as futures, forward foreign currency     
exchange contracts, swap contracts and options contracts. Amounts shown represent unrealized appreciation (depreciation),   
or in the case of options, market value at period end.       



The fund adopted Statement of Financial Accounting Standards No. 161 “Disclosures about Derivative Instruments and Hedging Activities” (“FAS 161”). FAS 161 requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of gains and losses on derivative instruments and disclosures about credit-risk-related contingent features in derivative agreements. Since the fund held no derivatives during the period, FAS 161 disclosures did not impact the notes to the financial statements.

Portfolio valuation: Investments in securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices, except for open short positions, where the asked price is used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. When market quotations or official closing prices are not readily available, or are determined not to reflect accurately fa ir value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board of Directors. Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant ADRs and futures contracts. For other securities that are fair valued by the Board of Directors, certain factors may be considered such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading



in similar securities of the issuer or comparable issuers. Financial futures are valued at the last sales price.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of Dreyfus, the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Manager, U.S. Government and Agency securities or letters of credit. The fund is entitled to receive all income on securities loaned, in addition to income earned as a result of the lending transaction. Although each security loaned is fully collateralized, the fund bears the risk of delay in recovery of, or loss of rights in, the securitie s loaned should a borrower fail to return the securities in a timely manner.

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the Securities and Exchange Commission on Form N-CSR.



Item 2.  Controls and Procedures. 

(a) The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-Q is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b) There were no changes to the Registrant's internal control over financial reporting that occurred during the Registrant's most recently ended fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 3.  Exhibits. 

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940.



FORM N-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

The Dreyfus Third Century Fund, Inc. 
 
By:  /s/ J. David Officer 
  J. David Officer 
  President 
 
Date:  October 28, 2009 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

By:  /s/ J. David Officer 
  J. David Officer 
President
 
Date:  October 28, 2009 
 
By:  /s/ James Windels 
  James Windels 
Treasurer
 
Date:  October 28, 2009 

EXHIBIT INDEX

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (EX-99.CERT)


EX-99.CERT 2 certification035.htm CERTIFICATION certification035.htm - Generated by SEC Publisher for SEC Filing

SECTION 302 CERTIFICATION

I, J. David Officer, certify that:

1. I have reviewed this report on Form N-Q of The Dreyfus Third Century Fund, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedule of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:  /s/ J. David Officer 
  J. David Officer 
President
Date:  October 28, 2009 



SECTION 302 CERTIFICATION

I, James Windels, certify that:

1. I have reviewed this report on Form N-Q of The Dreyfus Third Century Fund, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedule of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:  /s/ James Windels 
  James Windels 
Treasurer
Date:  October 28, 2009 


-----END PRIVACY-ENHANCED MESSAGE-----